SamanTree Medical - About the company
SamanTree Medical is a series C company based in Lausanne (Switzerland), founded in 2014 by Etienne Shaffer. It operates as a Developer of digital microscopy system for high-resolution imaging of tissue. SamanTree Medical has raised $57.5M in funding from investors like European Investment Bank, Panakes Partners and Relyens. The company has 109 active competitors, including 35 funded and 9 that have exited. Its top competitors include companies like Scholar Rock, Lucida Medical and Sysmex.
Company Details
Developer of digital microscopy system for high-resolution imaging of tissue. The system allows rapid imaging of fresh tissue surfaces without slicing. It uses confocal microscopy for tissue visualization while preserving the specimen. The system includes a fluorescent stain and single-use device for imaging. Digital tools allow physicians to review images remotely and annotate areas of interest.
- Website
- www.samantree.com/
- Social
- Registered Address
- Avenue de Provence 12, 1007 Lausanne, CH
Key Metrics
Founded Year
2014
Location
Lausanne, Switzerland
Stage
Series C
Total Funding
$57.5M in 10 rounds
Latest Funding Round
Investors
Ranked
3rd among 109 active competitors
Employee Count
64 as on Sep 30, 2026
Similar Companies
Legal entities associated with SamanTree Medical
SamanTree Medical is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Samantree Medical Sa CIN: 1205962 , Switzerland, Active | Mar 04, 2024 | - | - | - |
Sign up to download SamanTree Medical's company profile
SamanTree Medical's funding and investors
SamanTree Medical has raised a total funding of $57.5M over 10 rounds. Its first funding round was on Jan 12, 2015. Its latest funding round was a Series C round on Jan 27, 2026 for $*****. 1 investor participated in its latest round. SamanTree Medical has 16 institutional investors.
Here is the list of recent funding rounds of SamanTree Medical:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 27, 2026 | 6518615 | Series C | 1620971 | 8158332 | 9776710 | 7483028 |
Apr 04, 2025 | 5843165 | Series B | 3272483 | 7452418 | 4282276 | 1427476 |
Jul 16, 2024 | 2464855 | Series B | 8364508 | 7785987 |
Access funding benchmarks and valuations. Sign up today!View details of SamanTree Medical's funding rounds and investors
SamanTree Medical's founders and board of directors
Founder? Claim ProfileThe founders of SamanTree Medical is Etienne Shaffer. Olivier Delporte is the CEO of SamanTree Medical.
Here are the details of SamanTree Medical's key team members:
- Etienne Shaffer: CTO & ex-Co-Founder of SamanTree Medical. Contact Info: 1 email address
- Olivier Delporte: CEO of SamanTree Medical. Contact Info: 1 email address
View details of SamanTree Medical's Founder profiles and Board Members
SamanTree Medical's employee count trend
SamanTree Medical has 64 employees as of Sep 26. Here is SamanTree Medical's employee count trend over the years:
Uncover SamanTree Medical's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
SamanTree Medical's Competitors and alternates
Top competitors of SamanTree Medical include Scholar Rock, Lucida Medical and Sysmex. Here is the list of Top 10 competitors of SamanTree Medical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Scholar Rock 2012, Cambridge (United States), Public | Developer of Antibody-based drugs for the treatment of primary myopathies | $103M | 61/100 | |
2nd |  Lucida Medical 2019, Cambridge (United Kingdom), Series A | Developer of MRI-based cancer screening technology using artificial intelligence (AI) | $11.5M | 59/100 | |
3rd | SamanTree Medical 2014, Lausanne (Switzerland), Series C | Developer of digital microscopy system for high-resolution imaging of tissue | $57.5M | 61/100 | |
4th | Developer of diagnostic instruments, reagents, and related software | - | - | 55/100 | |
5th | Ionpath 2014, Menlo Park (United States), Series B | Developer of an imaging platform for tissue biopsies | $18M | 52/100 | |
6th | Developer of therapy-assist CT system for minimally invasive interventions | $8.4M | 52/100 | ||
7th | Provider of an AI-enabled immunotherapy based tumor diagnostic platform | $38.2M | 51/100 | ||
8th | Provider of magnetic probe based device of treatment of multiple cancer | $17.5M | 51/100 | ||
9th | Windtree Therapeutics 1992, Philadelphia (United States), Public | Developer of therapies for oncology and cardiovascular diseases with unmet needs | $45K | 50/100 | |
10th | Imagion Biosystems 2016, Albuquerque (United States), Public | Developer of molecular magnetic resonance imaging technology for cancer detection | - | 50/100 |
_1568349958328.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on SamanTree Medical's competitors? Click here to see the top ones
SamanTree Medical's Investments and acquisitions
SamanTree Medical has made no investments or acquisitions yet.
Reports related to SamanTree Medical
Here is the latest report on SamanTree Medical's sector:
News related to SamanTree Medical
Filter this listMedia has covered SamanTree Medical for a total of 4 events in the last 1 year, 1 of them has been about company updates.
•
•
SamanTree Medical Raises €20M in FundingFinSMEs•Jan 27, 2026•European Investment Bank, SamanTree Medical, Europa
•
•
SamanTree Medical Spotlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at SABCS 2024Business Wire•Dec 13, 2024•SamanTree Medical
•
SamanTree Medical Presents Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at SABCS 2024Business Wire•Dec 13, 2024•SamanTree Medical
•
SamanTree Medical Achieves FDA Clearance for Histolog® Scanner, Ushering in a New Era of Tissue Imaging in the U.S.Business Wire•Sep 13, 2024•SamanTree Medical
•
SamanTree Medical Raises $14M in Series B Financing Round to Support Global Expansion and Innovation in Surgical TreatmentBusiness Wire•Jul 16, 2024•SamanTree Medical, Relyens, Altur Investissement, Mutuelles Impact and 6 others
•
SamanTree Medical announces new clinical data at recent medical congresses in prostate, lung, breast, and brain cancer surgeryBusiness Wire•Sep 28, 2023•SamanTree Medical
•
•
SamanTree Medical SA Announces Exciting Clinical Data Showing the Potential of the Histolog® Scanner to Be a Valid Alternative to Frozen Section AnalyACROFAN•Dec 21, 2022•SamanTree Medical
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about SamanTree Medical
Explore our recently published companies
- Ankara Laser - Ankara based, 2002 founded, Unfunded company
- Casey Handmer - Unfunded company
- Klamra - Ukraine based, Unfunded company
- Tohtan - Japan based, 1955 founded, Unfunded company
- Mountain Top Universtity - Nigeria based, Unfunded company
- Laura Valley - Kingston based, Unfunded company
